6:30 am – 5:30 pm
6:30 am – 7:45 am
Continental Breakfast (pending corporate support)
7:15 am – 7:30 am
New Member and First-Time Attendee Welcome and Orientation
7:45 am – 8:00 am
Conference Welcome and Awards
8:00 am – 9:00 am
Do you sometimes just need to hear about the good things nurses do? Listen to this practical, realistic, and positive talk about the supportive and caring work of nursing. We will talk about what makes nurses tick, as well as what can tick us off! We will also laugh at some of the crazy and funny things that only nurses know. Sit back, relax, listen, laugh, and restore your pride as a professional nurse!
9:10 am – 10:25 am
10:25 am – 11:25 am
Exhibits / Posters / Silent Auction
The latest and the greatest in urology products and services are on display from the leading vendors in the marketplace. Exhibitors will be eager to speak with you about your patients’ needs and your professional responsibilities. Posters also will be on display during this time. In addition, you will have the opportunity to view Silent Auction items and bid on auction items.
11:25 am – 12:25 pm
12:30 pm – 1:45 pm
Corporate Luncheon / Product Theater
Corporate Luncheon / Product Theater
Sponsored by Astellas Pharma, US, Inc. and Pfizer Oncology
2:00 pm – 3:00 pm
Etai Goldenberg, MD
During this session, incidence, pathophysiology, typical presentation, and management of penile fractures will be described and discussed.
Assessment and Nonpharmacologic and Pharmacologic Management of Patients with Type 2 Diabetes and Lower Urinary Tract
Lisa S. Pair, DNP, WHNP-BC
Type 2 diabetes has long been associated with upper urinary tract or renal dysfunction associated with lower urinary tract symptoms (LUTS) and bladder dysfunction. Unmanaged, LUTS and bladder dysfunction can result in harmful complications leading to upper urinary tract impairment. The aim of this presentation is to review the effect of type 2 diabetes on lower urinary tract function and to provide non-pharmacologic and pharmacologic management strategies to optimize bladder function and reduce complications. A review of the American Diabetes Association guidelines will be presented. Clinical management guidelines following the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013 will be also be reviewed.
Pediatric Urodynamics – “What’s the Difference”
Shelly King, RN, MSN, CPNP
Pediatric urodynamics and how it differs from adult studies will be discussed in this lecture. Tips and tricks for performing studies will be provided. The lecture will also include a look at the complex congenital anomalies and how important urodynamics are to the treatment and management of these conditions. If you do many urodynamics on children or rarely perform these studies on kids, you will find this lecture helpful and enlightening.
Recent Advances in imaging in Urologic Oncology
David Ballard, MD
The purpose of this talk is to summarize current imaging practices in urologic oncology applications including prostate cancer, urothelial cancer, and renal cell carcinoma. Recent advances in nuclear medicine for prostate cancer imaging will be summarized including novel tracer agents for PET. Prostate MRI, CT and MR urography, along with conventional CT imaging will be discussed in the context of urologic malignancies.
3:00 pm – 4:30 pm
Exhibits Open / Refreshment Break / Posters / Silent Auction (bids close)
4:30 pm – 5:30 pm
Chronic Testicular Pain: Evaluation and Management
Dane Johnson, MD
Chronic testicular pain is a common urological complaint, representing up to 2.5% of all urologic visits in the US annually. Unfortunately, this pain complaint often proves to be a difficult problem to tackle, for both patient and provider. During this presentation we will review the various causes of Chronic Testicular Pain, and provide a structured overview of management decisions.
Considerations in the Endoscopic Management of BPH
Lisa Filipkowski, MD
This presentation addresses the reasons to consider progressing from medical to surgical management of BPH. Endoscopic treatment options are summarized, and considerations for the recommendation of each are discussed.
Urodynamic Assessment of Neurogenic Lower Urinary Tract Dysfunction
Mikel Gray, PhD, CUNP, CCCN, FAANP
Neurological diseases affecting the central nervous system also tend to influence lower urinary function. Historically referred to as neurogenic bladder dysfunction, neurogenic lower urinary tract dysfunction (NLUTD) is affected by the nature of the underlying neurological disorder, the patient’s age and sex, and other factors. The role and clinical utility of urodynamic testing in NLUTD associated with Parkinson Disease, Multiple Sclerosis, stroke and Alzheimer’s Disease and related dementias will be presented.
Use of Checkpoint Inhibitor Immunotherapy in Genitourinary Malignancies
Melissa A. Reimers, MD
Overview of recent treatment advances utilizing checkpoint inhibitor immunotherapy in urothelial carcinoma, renal cell carcinoma, and prostate cancer. Immune checkpoint inhibitors work by blocking checkpoint proteins from binding with these partner proteins. This prevents the “off” signal from being sent, allowing the T cells to kill cancer cells.
6:00 pm - 7:00 pm
Wine & Cheese / Product Theater
Next Generation Sequencing: Unmasking Refractory UTI and Chronic Pelvic Pain
Meghan Shotwell, PA-C
Sponsored by MicroGenDX